JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258273

Human UQCRQ knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

UQCRQ KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon3.
2 Images
Western blot - Human UQCRQ knockout HEK-293T cell lysate (AB258273)
  • WB

Lab

Western blot - Human UQCRQ knockout HEK-293T cell lysate (AB258273)

Lane 1 : Wild-type HEK-293T cell lysate 20 μg
Lane 2 : Uqcrq knockout HEK-293T cell lysate 20 μg
Lane 3 : Human Skeletal muscle cell lysate 20 μg
Lane 4 : Human Ovary cell lysate 20 μg
False colour image of Western blot : Anti-UQCRQ antibody staining at 1/1000 dilution, shown in black; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab241983 was shown to bind specifically to UQCRQ. A band was observed at 11 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in Uqcrq knockout cell line ab267244 (knockout cell lysate ab258273). To generate this image, wild-type and Uqcrq knockout HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 1 minute exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-UQCRQ antibody (<a href='/en-us/products/primary-antibodies/uqcrq-antibody-ab241983'>ab241983</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

Uqcrq knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human UQCRQ knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-uqcrq-knockout-hek-293t-cell-line-ab267244'>ab267244</a>)

Lane 3:

Human Skeletal muscle cell lysate at 20 µg

Lane 4:

Human Ovary cell lysate at 20 µg

Predicted band size: 10 kDa

Observed band size: 11 kDa

false

Sanger Sequencing - Human UQCRQ knockout HEK-293T cell lysate (AB258273)
  • Sanger seq

Unknown

Sanger Sequencing - Human UQCRQ knockout HEK-293T cell lysate (AB258273)

Homozygous : 1 bp deletion in exon3

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon3.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258273-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258273-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human UQCRQ knockout HEK293T cell lysate", "number":"AB258273-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
UQCRQ
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The UQCRQ protein also known as the ubiquinol-cytochrome c reductase complex III subunit VII has a mass of approximately 9.5 kDa. It is a component of the mitochondrial respiratory chain complex III. This protein is expressed in various tissues throughout the body with a higher concentration in tissues that require substantial energy production. UQCRQ plays a mechanical role in the electron transport chain facilitating the transfer of electrons between coenzyme Q and cytochrome c. This process contributes to the proton gradient used by ATP synthase for ATP synthesis.
Biological function summary

UQCRQ is a part of the cytochrome bc1 complex which is a critical enzyme in the mitochondrial inner membrane. This complex is essential in cellular respiration helping in the conversion of energy from nutrients into usable cellular energy in the form of ATP. The activity of UQCRQ is important for maintaining the efficiency of this larger complex and any disruption can significantly affect cellular energy homeostasis. UQCRQ supports the integrity of mitochondrial function impacting both energy production and reactive oxygen species management.

Pathways

UQCRQ is pivotal in oxidative phosphorylation and the electron transport chain specifically within the mitochondrial respiratory complex III. It works closely with other proteins in the complex such as cytochrome b and cytochrome c1 ensuring efficient electron transfer. Through these pathways UQCRQ contributes to oxidative stress regulation and cellular energy metabolism linking energy-producing mechanisms to broader cellular processes like apoptosis and cell growth.

UQCRQ has associations with mitochondrial disorders and myopathies. Mutations or dysfunctions in UQCRQ can lead to impaired energy production manifesting in conditions like mitochondrial encephalomyopathy and hypertrophic cardiomyopathy. The dysfunction in UQCRQ can affect proteins such as cytochrome c which plays a role in apoptosis potentially leading to neurodegenerative changes seen in mitochondrial-related diseases. Understanding the implications of UQCRQ in these conditions can guide the development of therapeutic strategies targeting mitochondrial dysfunction.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com